Central Iowa IA
Kimberly-Clark will buy Tylenol maker Kenvue in a $48.7 billion deal
Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company. Shareholders of Kimberly-Clark w…
